Invirsa

Company Profile

Invirsa's lead compound, INV-102, is derived from a naturally occurring molecule that combats viral conjunctivitis (viral pinkeye) by enhancing the body's own ability to fight the disease.

Company Info

HQ

Columbus, Ohio

Founded

2016

Founders and CEO

  • Robert Shalwitz, Founder and CEO

Sector

Biosciences